Article Information
History
- January 30, 2017.
Article Versions
- Version 1 (January 27, 2017 - 11:01).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Saurabh Mishra1,
- Prashant Shukla1,2,
- Ashima Bhaskar3,
- Kushi Anand1,
- Priyanka Baloni4,
- Rajeev Kumar Jha1,
- Abhilash Mohan4,
- Raju S. Rajmani1,
- V. Nagaraja1,5,
- Nagasuma Chandra4 and
- Amit Singh1,*
- 1Microbiology and Cell Biology, Centre for Infectious Disease and Research, Indian Institute of Science, Bangalore-12,
- 2International Centre for Genetic Engineering and Biotechnology, New Delhi-67, India,
- 3National Institute of Immunology, New Delhi-67,
- 4Department of Biochemistry, Indian Institute of Science, Bangalore-12,
- 5Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore-64, India.
- ↵* Correspondence: Amit Singh, Ph. D, Assistant Professor, Department of Microbiology and Cell Biology, Centre for Infectious Disease and Research, Indian Institute of Science, CV Raman Avenue, Bangalore-12, India Email: asingh{at}mcbl.iisc.ernet.in Ph: 91-80-22932604
Posted January 30, 2017.
Efficacy of the β-lactam\β-lactamase inhibitor combination is linked to WhiB4 mediated changes in redox physiology of Mycobacterium tuberculosis
